Clinical Conversations

This podcast features lively interviews, concise summaries, and expert commentary that busy clinicians need to stay current and improve patient care.

Articles matching the ‘Ribavirin’ Category

May 10th, 2020

Podcast 266: Interferon and early treatment in COVID-19 bring good outcomes

A combination of three antivirals — Kaletra (which is lopinavir plus ritonavir) and ribavirin — when given early and with interferon significantly reduces viral shedding, disease symptoms, and hospital stay in  patients with COVID-19 when compared with a control regimen of Kaletra alone. The drugs are active against other coronaviruses, but the key factors seem […]

Categories: antiviral drugs, Coronavirus, COVID-19, Hong Kong, Interferon, Kaletra, Lopinavir, NEWS2 (National Early Warning Score), Promptness of treatment, Ribavirin, Ritonavir
Tags: , , , ,

Clinical Conversations

About the Podcast

Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.

Follow us:
Follow on Apple Podcasts

Listen on Youtube

Follow on Spotify